About Robert Langer
Form D filings for Bilayer Therapeutics from 2021 to 2023 list Robert Langer as director.
Robert Langer first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Langer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Langer works with at each company, as listed on that company's latest Form D.
Bilayer Therapeutics, Inc. · Form D, Aug 4, 2023
JK
Joshua Korzenik
Director
TC
Thomas Collet
President and director
HC
Huang Yen-Chen
Director
DZ
David Zhu
Director
CT
Carlo Traverso
Director